BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 8888950)

  • 1. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
    Piercy KT; Björk AK; Myers RD
    Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited access to ethanol in genetic drinking rats is suppressed while feeding is enhanced by the mixed 5-HT1A agonist/5-HT2A antagonist FG5938.
    West MW; Kalmus G; Myers RD
    Pharmacol Biochem Behav; 1998 Aug; 60(4):823-8. PubMed ID: 9700964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of alcohol preference in high alcohol drinking rats: efficacy of amperozide versus naltrexone.
    Myers RD; Lankford MF
    Neuropsychopharmacology; 1996 Feb; 14(2):139-49. PubMed ID: 8822536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol intake in high alcohol drinking (HAD) rats is suppressed by FG5865, a novel 5-HT1A agonist/5-HT2 antagonist.
    Long TA; Kalmus GW; Björk A; Myers RD
    Pharmacol Biochem Behav; 1996 Jan; 53(1):33-40. PubMed ID: 8848457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-HT2 receptor blockade by amperozide suppresses ethanol drinking in genetically preferring rats.
    Myers RD; Lankford MF; Björk A
    Pharmacol Biochem Behav; 1993 Jul; 45(3):741-7. PubMed ID: 8332634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential efficacy of serotonergic drugs FG5974, FG5893, and amperozide in reducing alcohol drinking in P rats.
    Lankford MF; Björk AK; Myers RD
    Alcohol; 1996; 13(4):399-404. PubMed ID: 8836330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opiate and 5-HT2A receptors in alcohol drinking: preference in HAD rats is inhibited by combination treatment with naltrexone and amperozide.
    Lankford MF; Myers RD
    Alcohol; 1996; 13(1):53-7. PubMed ID: 8837935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective reduction by the 5-HT antagonist amperozide of alcohol preference induced in rats by systemic cyanamide.
    Myers RD; Lankford M; Björk A
    Pharmacol Biochem Behav; 1992 Nov; 43(3):661-7. PubMed ID: 1448464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of alcohol intake in diverse alcohol-preferring rat strains by the 5-HT2A antagonists amperozide and FG 5974.
    Overstreet DH; McArthur RA; Rezvani AH; Post C
    Alcohol Clin Exp Res; 1997 Nov; 21(8):1448-54. PubMed ID: 9394117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naltrexone and amperozide modify chocolate and saccharin drinking in high alcohol-preferring P rats.
    Biggs TA; Myers RD
    Pharmacol Biochem Behav; 1998 Jun; 60(2):407-13. PubMed ID: 9632223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive reduction of alcohol drinking by 5-HT1A antagonist WAY 100635 and serotonin uptake blocker fluoxetine in alcohol-preferring P rats.
    Zhou FC; McKinzie DL; Patel TD; Lumeng L; Li TK
    Alcohol Clin Exp Res; 1998 Feb; 22(1):266-9. PubMed ID: 9514317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol drinking in rats is attenuated by the mixed 5-HT1 agonist/5-HT2 antagonist FG 5893.
    Singh GK; Kalmus GW; Björk AK; Myers RD
    Alcohol; 1993; 10(3):243-8. PubMed ID: 8507395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT1A agonists: alcohol drinking in rats and squirrel monkeys.
    McKenzie-Quirk SD; Miczek KA
    Psychopharmacology (Berl); 2003 May; 167(2):145-52. PubMed ID: 12658527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irreversible suppression of alcohol drinking in cyanamide-treated rats after sustained delivery of the 5-HT2 antagonist amperozide.
    Myers RD; Lankford M; Björk A
    Alcohol; 1993; 10(2):117-25. PubMed ID: 8442888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats: involvement of presynaptic 5-HT1A receptors.
    Schreiber R; Opitz K; Glaser T; De Vry J
    Psychopharmacology (Berl); 1993; 112(1):100-10. PubMed ID: 7870997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of alcohol consumption by MDMA (ecstasy) in two strains of alcohol-preferring rats.
    Rezvani AH; Garges PL; Miller DB; Gordon CJ
    Pharmacol Biochem Behav; 1992 Sep; 43(1):103-10. PubMed ID: 1357675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of alcohol consumption by fenfluramine in Fawn-Hooded rats with serotonin dysfunction.
    Rezvani AH; Grady DR
    Pharmacol Biochem Behav; 1994 May; 48(1):105-10. PubMed ID: 8029280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium channel agonist (-)-BAY k 8644 suppresses free and limited access intake of alcohol in genetic drinking rats.
    West MW; Biggs TA; Schreiber R; De Vry J; Myers RD
    Psychopharmacology (Berl); 1999 Mar; 142(3):261-9. PubMed ID: 10208318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a metabotropic, mglu5, glutamate receptor antagonist on ethanol consumption by genetic drinking rats.
    McMillen BA; Crawford MS; Kulers CM; Williams HL
    Alcohol Alcohol; 2005; 40(6):494-7. PubMed ID: 16186143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of serotonin(1/2) receptor agonists on dark-phase food and water intake in rats.
    Schreiber R; Selbach K; Asmussen M; Hesse D; de Vry J
    Pharmacol Biochem Behav; 2000 Oct; 67(2):291-305. PubMed ID: 11124393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.